| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $118K | — | -50.6% |
| SG&A Expense | $379K | — | +20.8% |
| Operating Income | -$497K | — | +13.7% |
| Pre-tax Income | -$639K | — | -10.9% |
| Net Income | -$639K | — | -10.9% |
| EPS (Basic) | $0.00 | — | — |
| EPS (Diluted) | $0.00 | — | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $235K | -1.6% | -44.1% |
| Total Assets | $254K | -2.0% | -42.8% |
| Current Liabilities | $3.4M | +14.3% | +174.6% |
| Total Liabilities | $3.6M | +13.8% | +161.4% |
| Stockholders' Equity | -$3.3M | -15.3% | -259.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$404K | — | +19.1% |
| Financing Cash Flow | $200K | — | -33.3% |